Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
Lilly (LLY) Starts Website to Help Access Tirzepatide Drugs
12:02pm, Friday, 05'th Jan 2024
Eli Lilly's (LLY) digital pharmacy is expected to provide patients easy access to its FDA-approved tirzepatide medicines, Mounjaro and Zepbound.
Eli Lilly (LLY) Sees a More Significant Dip Than Broader Market: Some Facts to Know
06:48pm, Thursday, 04'th Jan 2024
In the latest trading session, Eli Lilly (LLY) closed at $614.50, marking a -0.52% move from the previous day.
Eli Lilly's DTC obesity drug push 'not necessarily an industry game changer': Mizuho's Jared Holz
06:25pm, Thursday, 04'th Jan 2024
Jared Holz, Mizuho health care sector strategist, joins 'Fast Money' to talk 'LillyDirect' and what it means for the health care sector as a whole.
Eli Lilly launches LillyDirect: What you need to know
02:23pm, Thursday, 04'th Jan 2024
The "Halftime Report" Investment Committee debate what the direct-to-consumer move means for the obesity drugmaker.
Eli Lilly launches website, home delivery option for Wegovy alternative Zepbound
11:48am, Thursday, 04'th Jan 2024
Lilly said its direct-to-consumer service will also be available for patients with diabetes and migraine, with the website's pharmacy page listing migraine drug Emgality, insulin and similar products
Eli Lilly launches 'LillyDirect': What this means for the pharma space
10:54am, Thursday, 04'th Jan 2024
Dr. Scott Gottlieb, former FDA commissioner and CNBC contributor, joins 'Squawk on the Street' to discuss Eli Lilly's launch of 'LillyDirect,' who gets hurt the most by the company's move, and more.
Eli Lilly Stock Hits Record on Drug Prescription Website
10:47am, Thursday, 04'th Jan 2024
Eli Lilly And Co (NYSE:LLY) today launched LillyDirect, a website that allows consumers with obesity to get prescriptions for its weight-loss drug Zepbound via telehealth, and offers home delivery o
Dr. Kavita Patel: Eli Lilly's direct-to-consumer portal will help patients get medications faster
10:06am, Thursday, 04'th Jan 2024
Dr. Kavita Patel, former White House health policy director, joins 'Squawk Box' to discuss news of Eli Lilly's launch of 'LillyDirect', an online direct-to-consumer pharmacy allowing people to get med
Pharmaceutical First: Eli Lilly Website Will Prescribe Weight Loss Drugs Through Service
09:51am, Thursday, 04'th Jan 2024
Drugmaker Eli Lilly has launched a new website specifically for prescribing weight loss drugs through a telehealth service less than a month after the company's new injectable, Zepbound, became availa
Eli Lilly stock climbs in 2024 on weight-loss drug outlook
09:48am, Thursday, 04'th Jan 2024
Eli Lilly and Co (NYSE:LLY) shares have gained more than 8% during the past five trading sessions on investor enthusiasm over prospects for the company's weight-loss drug Zepbound. In a client upda
2 Biotech Stocks For Your January 2024 Watchlist
09:41am, Thursday, 04'th Jan 2024
Biotech stocks to watch in the stock market today.
Eli Lilly goes direct-to-consumer on weight loss drugs: What patients and investors need to know
09:17am, Thursday, 04'th Jan 2024
Michael Yee, Jefferies senior biotech analyst, joins 'Squawk Box' to discuss news of Eli Lilly's launch of 'LillyDirect', an online direct-to-consumer pharmacy where patients can get the company's obe
Eli Lilly launches online direct-to-consumer pharmacy to help patients get weight loss drugs
08:32am, Thursday, 04'th Jan 2024
CNBC's Bertha Coombs joins 'Squawk Box' with the latest news.
Eli Lilly launches digital health services for patients with obesity, migraine and diabetes
07:57am, Thursday, 04'th Jan 2024
Eli Lilly & Co. LLY, +4.31% on Thursday announced the launch of digital health services for U.S. patients with obesity, migraine and diabetes, saying its new LillyDirect platform will offer access to
Lilly says it stands against cosmetic use of its weight-loss drugs
07:54am, Thursday, 04'th Jan 2024
Eli Lilly and Co said on Thursday it does not promote the use of its obesity and diabetes drugs Mounjaro and Zepbound outside of their approved purposes, and said it stands against their use for "cosm
